| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant! Online does not significantly influence adjuvant chemotherapy decisions of a breast cancer multidisciplinary team (MDT): a prospective study
|
Balakrishnan, A.
|
|
|
22 |
6 |
p. 1461-1462
|
artikel
|
| 2 |
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma
|
Chan, J.A.
|
|
|
22 |
6 |
p. 1367-1373
|
artikel
|
| 3 |
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer
|
Reck, M.
|
|
|
22 |
6 |
p. 1374-1381
|
artikel
|
| 4 |
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors
|
Jonker, D.J.
|
|
|
22 |
6 |
p. 1413-1419
|
artikel
|
| 5 |
Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
|
Schutz, F.A.B.
|
|
|
22 |
6 |
p. 1404-1412
|
artikel
|
| 6 |
Cancer-related fatigue: a practical review
|
Campos, M.P.O.
|
|
|
22 |
6 |
p. 1273-1279
|
artikel
|
| 7 |
Carbohydrate intake, glycemic load, glycemic index, and risk of ovarian cancer
|
Nagle, C.M.
|
|
|
22 |
6 |
p. 1332-1338
|
artikel
|
| 8 |
Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy
|
Harbeck, N.
|
|
|
22 |
6 |
p. 1250-1258
|
artikel
|
| 9 |
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study
|
Moehler, M.
|
|
|
22 |
6 |
p. 1358-1366
|
artikel
|
| 10 |
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
|
Vencken, P.M.L.H.
|
|
|
22 |
6 |
p. 1346-1352
|
artikel
|
| 11 |
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4)
|
Bertuccio, P.
|
|
|
22 |
6 |
p. 1420-1426
|
artikel
|
| 12 |
Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients
|
Reyal, F.
|
|
|
22 |
6 |
p. 1458-1459
|
artikel
|
| 13 |
Compliance with Good Clinical Practice in oncology registration trials in Japan
|
Yonemori, K.
|
|
|
22 |
6 |
p. 1451-1456
|
artikel
|
| 14 |
Correction to: Is FISH floating or still swimming in the lung cancer ocean?
|
|
|
|
22 |
6 |
p. 1467
|
artikel
|
| 15 |
Cost-utility and expected value of perfect information related to trabectedin in the treatment of metastatic soft-tissue sarcoma: the publicly funded comments explored
|
Soini, E.J.
|
|
|
22 |
6 |
p. 1465-1466
|
artikel
|
| 16 |
Different hepatitis B carrier categories need different management strategies in case of immunosuppressive chemotherapeutic regimens
|
Gigante, E.
|
|
|
22 |
6 |
p. 1462-1463
|
artikel
|
| 17 |
Editorial Board
|
|
|
|
22 |
6 |
p. ii-iii
|
artikel
|
| 18 |
Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis
|
Yamashita, H.
|
|
|
22 |
6 |
p. 1318-1325
|
artikel
|
| 19 |
Expression of androgen receptor in breast cancer and its significance as a prognostic factor
|
Yu, Q.
|
|
|
22 |
6 |
p. 1288-1294
|
artikel
|
| 20 |
FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer
|
Tamura, K.
|
|
|
22 |
6 |
p. 1302-1307
|
artikel
|
| 21 |
Gene regulatory networks: a new conceptual framework to analyse breast cancer behaviour
|
Demicheli, R.
|
|
|
22 |
6 |
p. 1259-1265
|
artikel
|
| 22 |
Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy?
|
Soria, J.-C.
|
|
|
22 |
6 |
p. 1247-1249
|
artikel
|
| 23 |
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
|
Hui, E.P.
|
|
|
22 |
6 |
p. 1280-1287
|
artikel
|
| 24 |
HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancer
|
Yao, L.
|
|
|
22 |
6 |
p. 1326-1331
|
artikel
|
| 25 |
Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods
|
Oakman, C.
|
|
|
22 |
6 |
p. 1295-1301
|
artikel
|
| 26 |
Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points
|
Lee, L.
|
|
|
22 |
6 |
p. 1392-1403
|
artikel
|
| 27 |
Incidence trends of melanoma of the skin compared with other localisations, in the Norwegian population, 1956–2005
|
Franco-Lie, I.
|
|
|
22 |
6 |
p. 1443-1450
|
artikel
|
| 28 |
Massage therapy for breast cancer patients: a systematic review
|
Lee, M.S.
|
|
|
22 |
6 |
p. 1459-1461
|
artikel
|
| 29 |
Medical oncology recognized at EU level to allow free movement of doctors: progress and challenge
|
Tanneberger, S.
|
|
|
22 |
6 |
p. 1457-1458
|
artikel
|
| 30 |
Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can)
|
Nagel, G.
|
|
|
22 |
6 |
p. 1339-1345
|
artikel
|
| 31 |
Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809
|
Ohmachi, K.
|
|
|
22 |
6 |
p. 1382-1391
|
artikel
|
| 32 |
Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer
|
Katsumata, N.
|
|
|
22 |
6 |
p. 1353-1357
|
artikel
|
| 33 |
Population attributable fraction of infection-related cancers in Korea
|
Shin, A.
|
|
|
22 |
6 |
p. 1435-1442
|
artikel
|
| 34 |
Rituxan is not associated with Stevens Johnson Syndrome
|
Henning, J.S.
|
|
|
22 |
6 |
p. 1463-1464
|
artikel
|
| 35 |
Second neoplasms after cancers of unknown primary
|
Levi, F.
|
|
|
22 |
6 |
p. 1464-1465
|
artikel
|
| 36 |
Survival in cancer patients with previous hospitalization for sarcoidosis: a Swedish population-based cohort study during 1964–2006
|
Shu, X.
|
|
|
22 |
6 |
p. 1427-1434
|
artikel
|
| 37 |
Table of Contents
|
|
|
|
22 |
6 |
p. iv-vi
|
artikel
|
| 38 |
Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years
|
Penel, N.
|
|
|
22 |
6 |
p. 1266-1272
|
artikel
|
| 39 |
The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis
|
Harris, C.A.
|
|
|
22 |
6 |
p. 1308-1317
|
artikel
|
Tijdschrift beschrijving